Delivery Order SPE2DR25D7062-SPE2DR26FW8VB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S, a topical pain management pharmaceutical product. This competitively awarded, non-set-aside delivery order is valued at $1,186.02 with a firm fixed price and an ultimate completion date of December 31, 2025. The award was executed on December 30, 2025, with performance to be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical. This competitive, non-set-aside contract is valued at $3,312.12 with a firm fixed price structure and an ultimate completion date of December 8, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,158.32 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of June 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product, with a contract value of $1,506.82. This firm fixed-price delivery order was competitively awarded without set-aside designations and carries an ultimate completion date of August 20, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,301.24 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of June 4, 2025, and was competitively awarded without any set-aside designation. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed-price delivery order, valued at $5,875.02, is scheduled for completion by November 18, 2025, and was awarded on November 17, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for Lidocaine 5% Patch 30s, with a ceiling value of $14,511.92. This firm fixed-price delivery order, which is set to complete by September 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $41,362.00 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with a ceiling value of $1,774.71 under a firm fixed-price contract type. The award was made on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a non-set-aside competitive award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units under a firm fixed-price contract valued at $4,631.44. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no...
- SPE2DR25D7062Indefinite Delivery Contract
- SPE2DR25D7062-SPE2DR26FW8VBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product, with a contract value of $4,791.36 under firm fixed-price terms. The award was issued on January 5, 2026, with an ultimate completion date of the same day, indicating expedited fulfillment of this medical supply requirement. The contract was competitively awarded with no set-aside designation, and performance is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications for pain management, diabetes, neurological conditions, and specialized medical commodities. The firm's extensive federal procurement experience and demonstrated capability to meet DLA requirements through open competition positioned it to fulfill this pharmaceutical delivery order supporting the Defense Health Agency and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 1/4/26 |